Validating Integrative Multi-omics Approaches in Metabolic Syndrome-related Diseases
Validating Integrative Multi-omics Approaches in Metabolic Syndrome-related Diseases: A Step Towards Precision Medicine
Chang Gung Memorial Hospital
6,266 participants
Jun 9, 2025
OBSERVATIONAL
Conditions
Summary
This study aims to validate integrative multi-omics approaches for understanding complications related to metabolic syndrome. By combining genetic, transcriptomic, metabolomic, and microbiome data from participants with and without metabolic syndrome, the research seeks to determine which biological factors predict disease progression and how these insights can inform precision prevention and treatment strategies for metabolic disorders.
Eligibility
Inclusion Criteria2
- Individuals (male or female) aged 20 years or older
- Willing and able to provide written informed consent to participate in the study
Exclusion Criteria5
- Pregnant or breastfeeding women
- Patients with end-stage renal disease receiving hemodialysis or peritoneal dialysis
- Individuals currently undergoing active cancer treatment
- Recipients of any organ transplantation
- Patients diagnosed with dementia
Interventions
no intervention
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07248371